Please login to the form below

Not currently logged in
Email:
Password:

hepatic encephalopathy

This page shows the latest hepatic encephalopathy news and features for those working in and with pharma, biotech and healthcare.

FDA approves two new IBS medicines

FDA approves two new IBS medicines

coli and for reduction of the risk in adult patients of recurring overt hepatic encephalopathy, the changes in brain function that occur when the liver is unable to remove toxins from

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals in February 2015 Pharma deals in February 2015

    Xifaxan is currently marketed for the treatment of hepatic encephalopathy and traveller's diarrhoea and nets $750m in sales, however, should the current FDA review for an inflammatory bowel disease with

  • Experience me: building engagement through experience Experience me: building engagement through experience

    It's a documentary. It tackles the challenge of convincing clinicians of the impact that the condition hepatic encephalopathy (HE) has on patients and their families, and thus stresses the need

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Infographics